Korean Post-marketing Surveillance for Xeljanz
NCT02984020 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1041
Last updated 2024-08-27
Summary
The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-13
- Primary Completion
- 2022-06-09
- Completion
- 2022-06-09
Countries
- South Korea
Study Locations
More Related Trials
-
Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients
NCT01270997 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
NCT01328522 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
NCT04428502 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
NCT01172639 ·Status: COMPLETED ·Phase: PHASE4
-
Study Investigating Enbrel Treatment for Ankylosing Spondylitis
NCT00195416 ·Status: COMPLETED
-
Surveillance of Humira in Korean JIA Patients
NCT02141984 ·Status: COMPLETED
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Leflunomide in Rheumatoid Arthritis
NCT00280644 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
NCT02094326 ·Status: COMPLETED
-
Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT01230177 ·Status: COMPLETED
-
Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
NCT00037700 ·Status: COMPLETED ·Phase: PHASE2
-
Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis
NCT00596206 ·Status: COMPLETED ·Phase: PHASE3
-
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
NCT01659242 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
NCT00195338 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
NCT00293709 ·Status: COMPLETED
-
A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis
NCT00888745 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France
NCT02927535 ·Status: COMPLETED
-
Faecal Analyses in Rheumatoid Arthritis Therapy
NCT03775824 ·Status: COMPLETED
-
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®
NCT01145950 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
NCT02486302 ·Status: COMPLETED
-
Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients
NCT04645420 ·Status: COMPLETED ·Phase: NA
-
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
NCT02115750 ·Status: COMPLETED ·Phase: PHASE3